PATENT CLAIM ANALYSIS

Application Number: 15750425
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "139100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 86):
The antibody or antigen binding fragment according to  claim 77 , wherein the antigen-binding fragment which binds to common \u03b3 chain comprises:\n (i) a light chain variable region comprising the following CDRs: \n LC-CDR1: (SEQ ID NO: 68) RSSQSLLHSNGYNYLD   LC-CDR2: (SEQ ID NO: 69) LGSNRDS   LC-CDR3: (SEQ ID NO: 70) MQGTHWPWT; (ii) a heavy chain variable region comprising the following CDRs: HC-CDR1: (SEQ ID NO: 48) GYYWS   HC-CDR2: (SEQ ID NO: 49) EINHSGSTNYNPSLKS   HC-CDR3: (SEQ ID NO: 77) SPGGYSGGYFQH.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15229336', '15495048', '15486468', '15521685', '15521434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739957820392689
- 35 USC 102 Novelty (BERT): 0.7280281273553973
- Combined Prediction Score: 0.7387648510889597
- Mean Citation Score: 532.3024059999998
- Max Citation Score: 948.52997
- Similarity Product: 772.4732692232203

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test